Post-Market Pulse: Tracking Health Sector's Closing Bell Shifts

After-Hours Ascenders in the Health Sector: Notable Increases

During Friday's extended trading period, several health care stocks demonstrated upward momentum. Leading these gains was Edesa Biotech, experiencing a substantial increase of 17.3%, pushing its market capitalization to $30.1 million. Following closely, Lunai Bioworks saw its shares rise by 6.78%, achieving a market valuation of $8.7 million. MindWalk Holdings also contributed to the positive trend, with its stock climbing 4.5% and reaching a market value of $54.6 million. Lexaria Bioscience's shares appreciated by 3.76%, resulting in a market cap of $19.2 million. Fractyl Health recorded a 3.54% increase, elevating its market value to $76.4 million. Lastly, Citius Pharmaceuticals saw a 2.96% rise in its share price, bringing its market value to $21.2 million.

Post-Trading Tumblers in Health Care: Significant Declines

Conversely, several health care stocks experienced downturns in Friday's after-market session. Harvard Bioscience led the declines with a 12.6% drop in its share price, settling at $0.48 and reducing its market value to $25.5 million. AN2 Therapeutics also saw a decrease, with its shares falling by 4.57%, placing its market cap at $46.8 million. Solid Biosciences' stock declined by 2.67%, resulting in a market value of $436.8 million. SCYNEXIS shares fell by 2.51% to $0.78, bringing its market value to $33.2 million, following its Q4 earnings report two days prior. Invivyd experienced a 2.23% decrease, with its market cap standing at $490.6 million after its Q4 earnings release yesterday. Finally, Lucid Diagnostics' stock dropped by 2.15%, with its market capitalization at $183.5 million.